Skip to Content

H23 (Minocycline hydrochloride extended-release 135 mg)

Pill imprint H23 has been identified as Minocycline hydrochloride extended-release 135 mg.

Minocycline is used in the treatment of bacterial infection; acne; rheumatoid arthritis; skin and structure infection; brucellosis (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substance Act (CSA).

Minocycline hydrochloride extended-release 135 mg H23
Discount Card Promo
Minocycline hydrochloride extended-release
Imprint:
H23
Strength:
135 mg
Color:
Brown
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Tetracyclines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Global Pharmaceuticals

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide